aurintricarboxylic acid has been researched along with gr 144053 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Kozawa, O; Matsuno, H; Niwa, M; Sakai, N; Uematsu, T | 1 |
| Boncler, M; Golanski, J; Rozalski, M; Watala, C | 1 |
2 other study(ies) available for aurintricarboxylic acid and gr 144053
| Article | Year |
|---|---|
Comparison of the antithrombotic effects and bleeding risk of fractionated aurin tricarboxylic acid and the GPIIb/IIIa antagonist GR144053 in a hamster model of stenosis.
Topics: Animals; Aurintricarboxylic Acid; Carotid Stenosis; Catheterization; Cricetinae; Endothelium, Vascular; Hemorrhage; Infusions, Intravenous; Male; Mesocricetus; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1999 |
Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation.
Topics: Adenosine Diphosphate; Adult; Aurintricarboxylic Acid; Cell Degranulation; Collagen Type I; Female; Flow Cytometry; Hemostasis; Humans; Male; Middle Aged; Piperazines; Piperidines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2001 |